Tenascin C-Guided Nanosystem for Precision Delivery of Obeticholic Acid in Liver Fibrosis Therapy
<b>Objective:</b> Liver fibrosis, a hallmark of chronic liver diseases, is characterized by excessive extracellular matrix (ECM) deposition and scar tissue formation. Current antifibrotic nanomedicines face significant limitations, including poor penetration into fibrotic tissue, rapid c...
Saved in:
Main Authors: | Yawen Wang, Lei Yang, Qing Xu, Taiyu Liu, Hongliang He, Lisha Liu, Lifang Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/32 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
by: Liangtao Zhao, et al.
Published: (2024-12-01) -
Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction
by: Pasquale Tondo, et al.
Published: (2025-01-01) -
Nanosystems for modulation of immune responses in periodontal therapy: a mini-review
by: Anirudh B. Acharya, et al.
Published: (2025-01-01) -
FACTORS AND ASPECTS OF THE RELOCATION STRATEGIES OF COMPANIES
by: SERGHEI MĂRGULESCU, et al.
Published: (2013-05-01) -
Antifibrotic Drug Delivery for Glaucoma Treatment – Determination of Josamycin in vivo
by: Eickner Thomas, et al.
Published: (2024-12-01)